Kazia Therapeutics Ltd ADR Cash Flow-to-Debt Ratio
Kazia Therapeutics Ltd ADR cash flow-to-debt ratio. Kazia Therapeutics Ltd ADR (KZIA) has a Cash Flow-to-Debt Ratio of -0.29x as of September 2025, meaning its operating cash flow of $-4.14 Million could theoretically repay 0% of its total liabilities ($14.36 Million) in one year. Check KZIA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Kazia Therapeutics Ltd ADR (1999–2025)
Cash flow-to-debt ratio of Kazia Therapeutics Ltd ADR from 1999 to 2025. Historical debt coverage capacity for Kazia Therapeutics Ltd ADR across 27 annual periods. Check Kazia Therapeutics Ltd ADR (KZIA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Kazia Therapeutics Ltd ADR Cash Flow-to-Debt Ratio by Year (1999–2025)
Kazia Therapeutics Ltd ADR cash flow-to-debt ratio by year from 1999 to 2025. Year-by-year debt coverage analysis for Kazia Therapeutics Ltd ADR. For the full cash flow conversion analysis, see KZIA cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.92x | $-13.28 Million | $14.36 Million | ▼ -204.9% |
| 2024 | -0.30x | $-9.58 Million | $31.60 Million | ▲ +67.9% |
| 2023 | -0.95x | $-15.16 Million | $16.03 Million | ▲ +26.9% |
| 2022 | -1.29x | $-22.76 Million | $17.61 Million | ▼ -187.0% |
| 2021 | -0.45x | $-9.11 Million | $20.24 Million | ▲ +54.3% |
| 2020 | -0.99x | $-8.81 Million | $8.94 Million | ▼ -2.9% |
| 2019 | -0.96x | $-6.71 Million | $7.01 Million | ▲ +1.2% |
| 2018 | -0.97x | $-8.66 Million | $8.93 Million | ▲ +10.4% |
| 2017 | -1.08x | $-11.43 Million | $10.57 Million | ▲ +85.7% |
| 2016 | -7.55x | $-11.98 Million | $1.59 Million | ▼ -133.1% |
| 2015 | -3.24x | $-5.76 Million | $1.78 Million | ▼ -84.3% |
| 2014 | -1.76x | $-5.71 Million | $3.25 Million | ▲ +22.6% |
| 2013 | -2.27x | $-8.79 Million | $3.87 Million | ▼ -19.7% |
| 2012 | -1.90x | $-7.35 Million | $3.87 Million | ▼ -81.2% |
| 2011 | -1.05x | $-8.70 Million | $8.31 Million | ▲ +61.4% |
| 2010 | -2.72x | $-16.61 Million | $6.11 Million | ▼ -19.6% |
| 2009 | -2.27x | $-20.60 Million | $9.07 Million | ▲ +12.3% |
| 2008 | -2.59x | $-20.10 Million | $7.76 Million | ▼ -19.3% |
| 2007 | -2.17x | $-14.63 Million | $6.74 Million | ▲ +2.1% |
| 2006 | -2.22x | $-14.44 Million | $6.52 Million | ▼ -21.0% |
| 2005 | -1.83x | $-12.76 Million | $6.97 Million | ▼ -409.1% |
| 2004 | -0.36x | $-10.48 Million | $29.12 Million | ▲ +48.3% |
| 2003 | -0.70x | $-5.83 Million | $8.38 Million | ▲ +18.2% |
| 2002 | -0.85x | $-6.68 Million | $7.86 Million | ▲ +54.7% |
| 2001 | -1.88x | $-34.18 Million | $18.22 Million | ▼ -22.9% |
| 2000 | -1.53x | $-18.75 Million | $12.29 Million | ▲ +39.0% |
| 1999 | -2.50x | $-20.97 Million | $8.39 Million | — |